Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows

v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (4,090,614) $ (3,496,432)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 622,537 627,315
Share based compensation 5,921 30,815
Credit loss provision 52,807 (25,079)
Provision to write down inventories to net realizable value (26,770) (10,855)
Amortization of right of use asset 77,086 86,201
Fair value remeasurement of contingent forward contract   (109,492)
Fair value remeasurement of contingent value rights   (19,179)
Gain (loss) on extinguishment of debt (332,412) 343,471
Gain on sale of assets (2,700)  
Interest and accretion expense 93,473 571,241
Changes in assets and liabilities:    
Trade and related party accounts receivables 942,875 978,228
Inventories, net (322,748) 205,946
Prepaid income taxes 11,173 14,615
Other assets 1,273,206 12,186
Accounts payable (2,782,565) (941,847)
Accrued compensation and benefits 132,016 20,770
Customer deposits (152,586) (443,775)
Other accrued liabilities (614,438) (148,679)
Accrued interest (50,358) (1,098,799)
Net cash used in operating activities (5,164,097) (3,403,349)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from the sale of property, plant and equipment 2,700  
Net cash provided by investing activities 2,700  
CASH FLOWS FROM FINANCING ACTIVITIES:    
Borrowings against related party working capital line of credit 800,000  
Payments against loans payable (851,616) (9,401,939)
Payments against related party loans payable (282,726)  
Payments related to equity issuance costs   (1,568,099)
Proceeds from the issuance of common stock and pre-funded warrants under registered direct offering   9,473,398
Proceeds from the issuance of common stock on the exercise of pre-funded warrants   11,078
Proceeds from the issuance of Series A and Series B warrants   5,515,525
Proceeds from the issuance of common stock under at-the-market offering   351,372
Payment of contingent consideration related to acquisition   (389,104)
Net cash (used in) provided by financing activities (334,342) 3,992,231
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH (5,495,739) 588,882
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD 7,182,344 1,151,348
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD 1,686,605 1,740,230
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:    
Interest paid $ 79,313 1,077,033
NONCASH FINANCING AND INVESTING ACTIVITIES:    
Loss on extinguishment of debt   (343,471)
Issuance of common stock for the settlement of loss contingencies   $ 880,756